Sector: Pharmaceuticals & Biotechnology
|Small Cap
Vivimed Labs Ltd.
₹6.50
₹6.46
₹6.65
₹5.15
₹29.40
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 11.63 | 18.66 | 17.94 | 22.58 | 34.23 |
| Operating Expense | 22.85 | 19.98 | 18.48 | 25.06 | 34.41 |
| Operating Profit | -11.22 | -1.32 | -0.54 | -2.48 | -0.18 |
| Depreciation | 4.40 | 4.68 | 4.80 | 4.61 | 6.37 |
| Interest | 0.94 | 1.60 | 0.52 | 1.48 | 0.43 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -16.57 | -7.44 | -5.50 | -4.42 | -6.97 |
₹6.50
↗ Bullish Moving Average
2
↘ Bearish Moving Average
14
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 20.9 | 20.9 | 7.8 | 7.8 | 7.8 | 7.6 |
| FII | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 |
| DII | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Public | 77.3 | 77.3 | 90.5 | 90.5 | 90.5 | 90.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.12 L | 2.12 L | 100.00% |
| Week | 1.19 L | 1.19 L | 100.00% |
| 1 Month | 1.12 L | 1.12 L | 100.00% |
| 6 Month | 2.32 L | 3.1 L | 74.74% |
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2018 | 0.4 | FINAL | Equity Share | |
| 21 Sep, 2017 | 0.4 | FINAL | Equity Share | |
| 24 Sep, 2014 | 3 | FINAL | Equity Share | |
| 24 Sep, 2013 | 3 | FINAL | Equity Share | |
| 21 Sep, 2012 | 3 | FINAL | Equity Share | |
| 26 Sep, 2011 | 2 | FINAL | Equity Share | |
| 09 Sep, 2010 | 1.5 | FINAL | Equity Share | |
| 24 Sep, 2009 | 1.5 | FINAL | Equity Share | |
| 22 Sep, 2008 | 1 | FINAL | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹494.20 | ₹118 | ₹132.50 | ₹13.78 | ₹18 |
| % Change | 1.54% | -4.84% | 1.85% | -0.93% | -1.37% |
| Revenue TTM (₹ Cr) | - | - | ₹287.68 | - | - |
| Net Profit TTM (₹ Cr) | - | - | ₹14.88 | - | - |
| PE TTM | - | 16.20 | 33.00 | - | 6.20 |
| 1 Year Return | 22.61 | -4.69 | 0.28 | 46.26 | -58.14 |
| ROCE | 28.91 | - | - | - | - |
Influx Healthtech Ltd.
₹ 243.00
-2.72%
Medicamen Organics Ltd.
₹ 24.80
+1.43%
Amrutanjan Health Care Ltd.
₹ 559.75
+0.46%
Innova Captab Ltd.
₹ 842.05
-0.74%
Valiant Laboratories Ltd.
₹ 77.00
+0.16%
Sigachi Industries Ltd.
₹ 20.42
+0.34%
Windlas Biotech Ltd.
₹ 773.05
-2.14%
Vineet Laboratories Ltd.
₹ 35.00
-1.69%
Solara Active Pharma Sciences Ltd.
₹ 555.65
+1.38%
Zim Laboratories Ltd.
₹ 102.50
+2.34%
Medico Remedies Ltd.
₹ 47.95
+0.23%
Dishman Carbogen Amcis Ltd.
₹ 200.00
+2.37%
Lasa Supergenerics Ltd.
₹ 8.09
+1.25%
Advanced Enzyme Technologies Ltd.
₹ 381.15
+1.60%
Bajaj Healthcare Ltd.
₹ 305.00
-0.18%
Ortin Global Ltd.
₹ 15.05
-3.53%
Brooks Laboratories Ltd.
₹ 56.41
+4.99%
RPG Life Sciences Ltd.
₹ 2275.90
-0.78%
Bafna Pharmaceuticals Ltd.
₹ 137.70
+1.98%
Alpa Laboratories Ltd.
₹ 69.15
-0.01%
SMS Pharmaceuticals Ltd.
₹ 365.00
-4.31%
Nectar Lifesciences Ltd.
₹ 12.39
+2.74%
Mangalam Drugs and Organics Ltd.
₹ 29.73
+1.09%
Indoco Remedies Ltd.
₹ 198.53
-0.28%
By signing up I certify terms, conditions & privacy policy